NCT06000644

Brief Summary

The objective of this study is to compare the effects of progressive combined cognitive training and rhythmic auditory stimulation to treadmill training (combined group), cognitive treadmill training (cognitive group), rhythmic auditory stimulation to treadmill training (rhythmic group), and treadmill walking alone (treadmill group) on walking automaticity, executive function, and dual-task coordination for patients with chronic stroke (Aim 1). The second aim of this study is to investigate the factors affecting the results of interventions (Aim 2). The third aim of the study is to examine the characteristics of stroke population who are appropriate for progressive combined cognitive training and rhythmic auditory stimulation to treadmill training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

August 30, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 23, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 23, 2026

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2.5 years

First QC Date

August 11, 2023

Last Update Submit

March 17, 2026

Conditions

Keywords

strokegait rehabilitationrhythmic auditory stimulationcognitive training

Outcome Measures

Primary Outcomes (4)

  • Walking speed (m/s)

    Participants will walk 10 meters at their preferred speed with and without the Stroop task twice, respectively. The spatiotemporal gait parameters will be examined using Physilog® sensors (Gait Up, Switzerland) and analyzed by the Gait Analysis Package software on the USB key. Walking speed (m/s) is the mean speed of forward walking, calculated in meters per second.

    5 minutes

  • Stride time variability (%)

    The stride time is the duration of one cycle (from heel strike to heel strike of the same side). Stride time variability (%) is the coefficient of variation of stride time or cycle duration in percent.

    5 minutes

  • Gait asymmetry (%)

    Gait asymmetry will be assessed by comparing left and right swing time, in percent. A perfect symmetry outputs a value of 0%.

    5 minutes

  • Cognitive composite score

    The Stroop task is the commonly utilized dual-task paradigm and measures executive function and response inhibition, which plays a vital role during walking. Therefore, the Stroop task will be selected to assess cognitive dual-task walking. The Stroop task will be performed while sitting and walking to assess executive function under single-task and dual-task conditions. The following is the formula for calculating the cognitive composite score: Cognitive composite score of the Stroop task = \[Accuracy(%)/Reaction time(milliseconds)\] \* 100. The better the cognitive performance of the Stroop task, the higher the cognitive composite score. The instructions for the dual-task walking (walking + Stroop) are designed to encourage neutral prioritization between the two tasks ("walk at the preferred speed while performing the Stroop task as accurately and quickly as you can").

    5 minutes

Secondary Outcomes (7)

  • Dual-task automaticity

    5 minutes

  • Task-specific dual-task interference

    5 minutes

  • 6-minute Walking test, 6MWT

    6 minutes

  • Stroke impact scale, SIS

    10 minutes

  • Mini-Balance Evaluation System Test, Mini-BESTest

    10 minutes

  • +2 more secondary outcomes

Study Arms (4)

combined group

EXPERIMENTAL

The combined group will undertake progressive treadmill walking speed while performing a cognitive task with rhythmic auditory cueing.

Device: Combined group

cognitive group

ACTIVE COMPARATOR

The cognitive group will receive cognitive training while walking on the treadmill.

Device: Cognitive group

rhythmic group

ACTIVE COMPARATOR

The rhythmic group will hear rhythmic auditory stimulation while treadmill walking.

Device: Rhythmic group

treadmill group

ACTIVE COMPARATOR

The treadmill group will train only in progressive treadmill walking.

Device: Treadmill group

Interventions

The combined group will undertake progressive treadmill walking speed while performing a cognitive task with rhythmic auditory cueing for 30 minutes per session, 3 times a week for 4 weeks.

combined group

The cognitive group will receive cognitive training while treadmill walking with a progressive speed for 30 minutes per session, 3 times a week for 4 weeks .

cognitive group

The rhythmic group will hear rhythmic auditory stimulation while treadmill walking for 30 minutes per session, 3 times a week for 4 weeks.

rhythmic group

The treadmill group will train only in progressive treadmill walking for 30 minutes per session, 3 times a week for 4 weeks.

treadmill group

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with first-time stroke;
  • more than 6 months after stroke onset;
  • able to walk 10 meters;
  • no severe vision, hearing, or speech impairments;
  • understand and follow the instructions and sign the Informed Consent Form;
  • older than 20 years old.

You may not qualify if:

  • orthopedic problems affecting walking or other diseases that may interfere with study participation;
  • a score of less than 24 on the mini-mental state examination (MMSE);
  • severe balance disorder with a total score of less than 45 points Berg Balance Scale.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mackay Memory Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Li-Ling Chuang, Ph.D.

    Chang Gung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated Professor

Study Record Dates

First Submitted

August 11, 2023

First Posted

August 21, 2023

Study Start

August 30, 2023

Primary Completion

February 23, 2026

Study Completion

February 23, 2026

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations